Analysis of PTPN11 mutation in children leukemia and its clinical significance.
- Author:
San-Zhen YANG
1
;
Bing-Qiang CHEN
;
Su-Ying LU
;
Bi-Hong ZHANG
;
Hong-Man XUE
;
Chun CHEN
Author Information
1. Department of Pediatrics, The People Hospital of Gaozhou, Gaozhou, Guangdong Province, China.
- Publication Type:Journal Article
- MeSH:
Adolescent;
Base Sequence;
Child;
Child, Preschool;
Female;
Humans;
Infant;
Leukemia;
genetics;
Male;
Mutation;
Protein Tyrosine Phosphatase, Non-Receptor Type 11;
genetics
- From:
Journal of Experimental Hematology
2012;20(1):22-25
- CountryChina
- Language:Chinese
-
Abstract:
This study was aimed to explore the frequency of PTPN11 mutation in children with leukemia and its clinical significance. Genomic DNAs were extracted from peripheral leukocytes of 131 patients with leukemia, including 101 cases of ALL, 26 cases of AML, 3 cases of CML and 1 case of juvenil myelomonocytic leukemia (JMML). The sequences of PTPN11 exons 3, 8, 13 were amplified by polymerase chain reaction (PCR), and the clinical characteristics of positive patients were analyzed. The results indicated that the PTPN11 mutation was found in 10 cases (9.9%) from newly diagnosed 101 cases of ALL. Grouping the newly diagnosed ALL children by various clinical features, it was found that the PTPN11 mutation did not show associations with sex, age, white blood cell (WBC) count, prednisone test sensitivity, clinical risk and disease recurrences at the first visit (P > 0.05). PTPN11 mutations were found in 2 cases out of 26 AML patients, including one AML-M(2) and one AML-M(4). No PTPN11 mutation in 3 CML patients was found. Exon 13 mutation of PTPN11 gene was found in 1 case of JMML. It is concluded that the E76 of exon 3 is the hot spot of PTPN11 mutation in children leukemia. The novel G503E (1508G > A) mutation is detected in one JMML patient. The PTPN11 mutation does not associate with the sex, age, WBC count, prednisone sensitive test and early recurrence.
